SLDB Operating Cash Flow (Statement)
Solid Biosciences Inc · Operating Cash Flow (Statement)
SLDB Operating Cash Flow (Statement)
Latest reported-$186.84Mperiod ending
SLDB Cash from Operations (-$4.20M → -$186.84M)
Annual operating cash flow (statement)
High-resolution chart · PNG
SLDB operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -156,289,000 | |
| -100,012,000 | |
| -94,180,000 | |
| -97,977,000 | |
| -77,764,000 | |
| -56,599,000 | |
| -92,714,000 | |
| -70,197,000 | |
| -43,224,000 | |
| -20,120,000 | |
| -4,204,000 |